The role of hypoglycemic sulphonylureas in arrhythmias contributing to the mortality in acute myocardial ischemia.
作者信息
Koltai M Z, Aranyi Z, Ballagi-Podány G, Pogátsa G
机构信息
National Institute of Cardiology, Budapest, Hungary.
出版信息
Acta Physiol Hung. 1990;75 Suppl:175-6.
PMID:2371854
Abstract
摘要
相似文献
1
The role of hypoglycemic sulphonylureas in arrhythmias contributing to the mortality in acute myocardial ischemia.
Acta Physiol Hung. 1990;75 Suppl:175-6.
2
Effect of diabetes mellitus and its treatment on ventricular arrhythmias complicating acute myocardial infarction.
Diabet Med. 2005 May;22(5):576-82. doi: 10.1111/j.1464-5491.2005.01468.x.
3
Possible risk of sulphonylureas in the treatment of non-insulin-dependent diabetes mellitus and coronary artery disease.
Diabetologia. 1998 Jun;41(6):743-4. doi: 10.1007/s001250050981.
4
Cardiac complications in patients with diabetes mellitus.
Angiology. 1978 Dec;29(12):907-10. doi: 10.1177/000331977802901205.
5
[Effect of antidiabetic treatment in ischemic heart diseases].
Orv Hetil. 1990 Jan 21;131(3):119-26.
6
Sulfonylureas and the risk of myocardial infarction.
Metabolism. 2006 May;55(5 Suppl 1):S16-9. doi: 10.1016/j.metabol.2006.02.004.
7
Diabetes and coronary heart disease.
N Engl J Med. 1998 Dec 3;339(23):1715; author reply 1716.
8
A comment on 'the risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy'.
Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1072-3; author reply 1073-4. doi: 10.1002/pds.1465.
9
Oral sulfonylureas and CV mortality.
Geriatrics. 2004 Sep;59(9):45-6, 49.
10
Sulfonylureas and mortality in diabetic patients after myocardial infarction.
Circulation. 1998 Feb 24;97(7):709-10.
Zotero 插件